
Luminex Corp - Product Pipeline Analysis, 2022 Update
Description
Summary
Luminex Corp (Luminex) develops, manufactures and markets proprietary biological testing technologies. The company offers a wide range of products including assays, instruments, reagents and accessories, software and replacement parts. It employs proprietary technologies to test for proteins and nucleic acids, and to serve multiplexing, precision, sensitivity, accuracy, and for reduction of labor. Luminex offers its products to various markets such as pharmaceutical drug discovery; clinical diagnostics; biomedical research including personalized medicine and genomic research. The company sells its products through direct sales channel and strategic distribution partners in Asia-Pacific North America and Europe. Luminex is headquartered in Texas, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Luminex Corp (Luminex) develops, manufactures and markets proprietary biological testing technologies. The company offers a wide range of products including assays, instruments, reagents and accessories, software and replacement parts. It employs proprietary technologies to test for proteins and nucleic acids, and to serve multiplexing, precision, sensitivity, accuracy, and for reduction of labor. Luminex offers its products to various markets such as pharmaceutical drug discovery; clinical diagnostics; biomedical research including personalized medicine and genomic research. The company sells its products through direct sales channel and strategic distribution partners in Asia-Pacific North America and Europe. Luminex is headquartered in Texas, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Luminex Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
63 Pages
- Luminex Corp Company Overview
- Luminex Corp Company Snapshot
- Luminex Corp Pipeline Products and Ongoing Clinical Trials Overview
- Luminex Corp – Pipeline Analysis Overview
- Business Description
- Luminex Corp - Key Facts
- Luminex Corp - Major Products and Services
- Luminex Corp Pipeline Products by Development Stage
- Luminex Corp Ongoing Clinical Trials by Trial Status
- Luminex Corp Pipeline Products Overview
- ARIES - Tuberculosis Assay
- ARIES - Tuberculosis Assay Product Overview
- ARIES Flu A/B/RSV/SARS-CoV-2 Assay
- ARIES Flu A/B/RSV/SARS-CoV-2 Assay Product Overview
- Aries LDT Cartridge
- Aries LDT Cartridge Product Overview
- Aries V2
- Aries V2 Product Overview
- Atlas System - Enteric Assay
- Atlas System - Enteric Assay Product Overview
- Companion Diagnostic Device - Alzheimer's Disease
- Companion Diagnostic Device - Alzheimer's Disease Product Overview
- Diagnostic Assay - MRSA
- Diagnostic Assay - MRSA Product Overview
- Diagnostic Assay - RVP II
- Diagnostic Assay - RVP II Product Overview
- Fungal Panel Assay
- Fungal Panel Assay Product Overview
- LX200/FM3D Convalescent Serum - COVID-19
- LX200/FM3D Convalescent Serum - COVID-19 Product Overview
- LX200/FM3D Immunity Status - COVID-19
- LX200/FM3D Immunity Status - COVID-19 Product Overview
- Magpix - Ebola Virus Assay
- Magpix - Ebola Virus Assay Product Overview
- Magpix Convalescent Serum - COVID-19
- Magpix Convalescent Serum - COVID-19 Product Overview
- Magpix Serology Immunity Status - COVID-19
- Magpix Serology Immunity Status - COVID-19 Product Overview
- Magpix Syndromic Dx - COVID-19
- Magpix Syndromic Dx - COVID-19 Product Overview
- Meningitis Panel Assay
- Meningitis Panel Assay Product Overview
- NxTAG Respiratory Pathogen Panel - Expanded Version
- NxTAG Respiratory Pathogen Panel - Expanded Version Product Overview
- Portable Field Deployed Diagnostic Tool
- Portable Field Deployed Diagnostic Tool Product Overview
- Verigene I Acute Dx - COVID-19
- Verigene I Acute Dx - COVID-19 Product Overview
- VERIGENE I SARS-CoV-2
- VERIGENE I SARS-CoV-2 Product Overview
- Verigene II Acute Dx - COVID-19
- Verigene II Acute Dx - COVID-19 Product Overview
- Verigene II Gastrointestinal Flex Assay
- Verigene II Gastrointestinal Flex Assay Product Overview
- Verigene II Gastrointestinal Flex Assay Clinical Trial
- Verigene II Respiratory Flex Assay
- Verigene II Respiratory Flex Assay Product Overview
- VERIGENE II SARS-CoV-2
- VERIGENE II SARS-CoV-2 Product Overview
- Verigene II Syndromic Dx - COVID-19
- Verigene II Syndromic Dx - COVID-19 Product Overview
- Verigene II System
- Verigene II System Product Overview
- Verigene II System - Blood Culture ID Assay
- Verigene II System - Blood Culture ID Assay Product Overview
- Verigene II System - Meningitis Panel
- Verigene II System - Meningitis Panel Product Overview
- Verigene II System - Syndromic Assay
- Verigene II System - Syndromic Assay Product Overview
- xMAP-Powered Assay - Breast Cancer
- xMAP-Powered Assay - Breast Cancer Product Overview
- Luminex Corp - Key Competitors
- Luminex Corp - Key Employees
- Luminex Corp - Key Employee Biographies
- Luminex Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Luminex Corp, Recent Developments
- Nov 22, 2021: RD-Biotech expands antibody and immunoassay services with xMAP Technology
- Mar 09, 2021: Luminex to Participate at the 2021 Barclays Global Healthcare Conference
- Feb 08, 2021: Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results
- Oct 07, 2020: For COVID-19 detection and epidemiology, xMAP technology offers unique advantages
- Mar 31, 2020: AdvaMed: COVID-19 test availability rapidly scales up
- Mar 04, 2020: Luminex provides updates on critical efforts related to novel coronavirus
- Feb 24, 2020: Luminex submits VERIGENE II Respiratory Flex Assay for FDA clearance
- Feb 10, 2020: Luminex reports fourth quarter and full-year 2019 results
- Jan 23, 2020: Luminex To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020
- Nov 04, 2019: Luminex Corporation reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Luminex Corp Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Luminex Corp Pipeline Products by Equipment Type
- Table 3: Luminex Corp Pipeline Products by Indication
- Table 4: Luminex Corp, Key Facts
- Table 5: Luminex Corp, Major Products and Services
- Table 6: Luminex Corp Number of Pipeline Products by Development Stage
- Table 7: Luminex Corp Pipeline Products Summary by Development Stage
- Table 8: Luminex Corp Ongoing Clinical Trials by Trial Status
- Table 9: Luminex Corp Ongoing Clinical Trials Summary
- Table 10: ARIES - Tuberculosis Assay - Product Status
- Table 11: ARIES - Tuberculosis Assay - Product Description
- Table 12: ARIES Flu A/B/RSV/SARS-CoV-2 Assay - Product Status
- Table 13: ARIES Flu A/B/RSV/SARS-CoV-2 Assay - Product Description
- Table 14: Aries LDT Cartridge - Product Status
- Table 15: Aries LDT Cartridge - Product Description
- Table 16: Aries V2 - Product Status
- Table 17: Aries V2 - Product Description
- Table 18: Atlas System - Enteric Assay - Product Status
- Table 19: Atlas System - Enteric Assay - Product Description
- Table 20: Companion Diagnostic Device - Alzheimer's Disease - Product Status
- Table 21: Companion Diagnostic Device - Alzheimer's Disease - Product Description
- Table 22: Diagnostic Assay - MRSA - Product Status
- Table 23: Diagnostic Assay - MRSA - Product Description
- Table 24: Diagnostic Assay - RVP II - Product Status
- Table 25: Diagnostic Assay - RVP II - Product Description
- Table 26: Fungal Panel Assay - Product Status
- Table 27: Fungal Panel Assay - Product Description
- Table 28: LX200/FM3D Convalescent Serum - COVID-19 - Product Status
- Table 29: LX200/FM3D Convalescent Serum - COVID-19 - Product Description
- Table 30: LX200/FM3D Immunity Status - COVID-19 - Product Status
- Table 31: LX200/FM3D Immunity Status - COVID-19 - Product Description
- Table 32: Magpix - Ebola Virus Assay - Product Status
- Table 33: Magpix - Ebola Virus Assay - Product Description
- Table 34: Magpix Convalescent Serum - COVID-19 - Product Status
- Table 35: Magpix Convalescent Serum - COVID-19 - Product Description
- Table 36: Magpix Serology Immunity Status - COVID-19 - Product Status
- Table 37: Magpix Serology Immunity Status - COVID-19 - Product Description
- Table 38: Magpix Syndromic Dx - COVID-19 - Product Status
- Table 39: Magpix Syndromic Dx - COVID-19 - Product Description
- Table 40: Meningitis Panel Assay - Product Status
- Table 41: Meningitis Panel Assay - Product Description
- Table 42: NxTAG Respiratory Pathogen Panel - Expanded Version - Product Status
- Table 43: NxTAG Respiratory Pathogen Panel - Expanded Version - Product Description
- Table 44: Portable Field Deployed Diagnostic Tool - Product Status
- Table 45: Portable Field Deployed Diagnostic Tool - Product Description
- Table 46: Verigene I Acute Dx - COVID-19 - Product Status
- Table 47: Verigene I Acute Dx - COVID-19 - Product Description
- Table 48: VERIGENE I SARS-CoV-2 - Product Status
- Table 49: VERIGENE I SARS-CoV-2 - Product Description
- Table 50: Verigene II Acute Dx - COVID-19 - Product Status
- Table 51: Verigene II Acute Dx - COVID-19 - Product Description
- Table 52: Verigene II Gastrointestinal Flex Assay - Product Status
- Table 53: Verigene II Gastrointestinal Flex Assay - Product Description
- Table 54: Verigene II Gastrointestinal Flex Assay - A Clinical Study of Gastrointestinal (GI) Assay on VERIGENE II System in the Detection of Gastrointestinal Infections
- Table 55: Verigene II Respiratory Flex Assay - Product Status
- Table 56: Verigene II Respiratory Flex Assay - Product Description
- Table 57: VERIGENE II SARS-CoV-2 - Product Status
- Table 58: VERIGENE II SARS-CoV-2 - Product Description
- Table 59: Verigene II Syndromic Dx - COVID-19 - Product Status
- Table 60: Verigene II Syndromic Dx - COVID-19 - Product Description
- Table 61: Verigene II System - Product Status
- Table 62: Verigene II System - Product Description
- Table 63: Verigene II System - Blood Culture ID Assay - Product Status
- Table 64: Verigene II System - Blood Culture ID Assay - Product Description
- Table 65: Verigene II System - Meningitis Panel - Product Status
- Table 66: Verigene II System - Meningitis Panel - Product Description
- Table 67: Verigene II System - Syndromic Assay - Product Status
- Table 68: Verigene II System - Syndromic Assay - Product Description
- Table 69: xMAP-Powered Assay - Breast Cancer - Product Status
- Table 70: xMAP-Powered Assay - Breast Cancer - Product Description
- Table 71: Luminex Corp, Key Employees
- Table 72: Luminex Corp, Key Employee Biographies
- Table 73: Luminex Corp, Other Locations
- Table 74: Luminex Corp, Subsidiaries
- Table 75: Glossary
- List of Figures
- Figure 1: Luminex Corp Pipeline Products by Equipment Type
- Figure 2: Luminex Corp Pipeline Products by Development Stage
- Figure 3: Luminex Corp Ongoing Clinical Trials by Trial Statuse
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.